ReWalk Robotics to Report Second Quarter 2022 Financial Results on August 9, 2022

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Aug. 03, 2022 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its second quarter 2022 financial results on Tuesday, August 9, 2022, at 8:30 AM Eastern time.

Larry Jasinski, Chief Executive Officer, and Almog Adar, Director of Finance, will host a conference call to discuss the results as follows:

Time 8:30 A.M EDT
Toll free (U.S.) (866) 374-5140
International (U.S) (404) 400-0571
Germany 8001897777
Israel 4044000571
Access Code 43100176#
Webcast (live and replay) https://edge.media-server.com/mmc/p/fz7je7rr under the ‘Investors’ section’.

The archived webcast will be available via the following link
https://edge.media-server.com/mmc/p/fz7je7rr or through the ‘Investors’ section’ on www.rewalk.com.

About ReWalk Robotics Ltd.

ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.  ReWalk’s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit www.rewalk.com.

ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel and the Unites States. 

Investor Contact:
Almog Adar
Director of Finance 
ReWalk Robotics Ltd.
T: +972-4-9590130
E: investorrelations@rewalk.com

Staff

Recent Posts

Onsite Mammography Provides Notice of Data Incident

BOSTON, April 21, 2025 /PRNewswire/ -- Onsite Mammography ("Onsite") announces a data incident that impacted…

1 hour ago

Lumenis Unveils Enhanced SPLENDOR X™ Laser Hair Removal Solution with New Clinical Data at the Annual American Society for Laser Medicine and Surgery (ASLMS) Conference

New data demonstrates effectiveness of SPLENDOR X™'s dual-wavelength simultaneous laser emission technology for improved hair…

1 hour ago

Havas Health Network and Republica Havas Health Unveil Report on Inequities in HCP Training and Practices

"The Hidden Divide" Exposes Gaps in Healthcare Provider Education and Care Delivery MIAMI, April 21,…

7 hours ago

K-679: A Novel Antibody Drug-loaded Unimicelle Conjugate with Ultra-High Drug Loading Capacity Demonstrates Superior Efficacy in EGFR-Expressing Solid Tumors

NAGOYA, Japan, April 21, 2025 /PRNewswire/ -- Kowa Company, Ltd. (Headquarters: Nagoya, Aichi Prefecture, Japan), today announced…

7 hours ago

Zimmer Biomet Completes Acquisition of Paragon 28

Transaction Further Strengthens Company's Position in High-Growth Foot and Ankle Segment WARSAW, Ind., April 21, 2025…

7 hours ago

CathVision to Exhibit the Latest Advancements in Electrophysiology at Heart Rhythm Society 2025 in San Diego

COPENHAGEN, Denmark, April 21, 2025 /PRNewswire/ -- CathVision, a leader in advanced cardiac electrophysiology (EP)…

7 hours ago